Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots—A new collection method for remote settings
Hanna Huber(University Hospital Bonn), Laia Montoliu‐Gaya(Sahlgrenska University Hospital), Maribel Ramis(Universitat Internacional de Catalunya), Kaj Blennow(Sahlgrenska University Hospital), Juan Lantero‐Rodriguez(University of Gothenburg), Adelina Orellana(Universitat Internacional de Catalunya), Raúl Núñez‐Llaves(Universitat Internacional de Catalunya), Merçé Boada(Instituto de Salud Carlos III), Xavier Morató(Fundació ACE), Andreas Jeromin(Cohen Veterans Bioscience), Johanna Nilsson(University of Gothenburg), Fernando García‐Gutiérrez(Universitat Internacional de Catalunya), Haley Weninger(Sahlgrenska University Hospital), Henrik Zetterberg(University of Wisconsin System), Nicholas J. Ashton(King's College London), Núria Aguilera(Universitat Internacional de Catalunya), Joel Simrén(University of Gothenburg)
Cited by 44
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k